¼¼°èÀÇ ¹ß±âºÎÀü ½ÃÀå º¸°í¼­(2025³â)
Erectile Dysfunction Global Market Report 2025
»óǰÄÚµå : 1720794
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 175 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,181,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 8,934,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,688,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¹ß±âºÎÀü Ä¡·áÁ¦ ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³â µ¿¾È °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2029³â±îÁö 8.9%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î 37¾ï 8,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾È ¼ºÀåÀÇ ¿øµ¿·ÂÀº ½É¸®Àû ¿äÀÎ Áõ°¡, ºñ¸¸ ¹× ´ë»ç ÀÌ»ó ºñÀ² Áõ°¡, ºñħ½ÀÀû ¹ß±âºÎÀü Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ¼º °Ç°­ °ü·Ã ȯÀÚ »ó´ã °Ç¼ö Áõ°¡, ³²¼º °Ç°­ ÁõÁø ¹× »ýȰ½À°ü °ü·Ã À§Çè ¿äÀο¡ ´ëÇÑ Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê Áõ°¡ µîÀÌ µÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. µîÀÌ ¿¹»óµË´Ï´Ù. ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ¹ß±âºÎÀü Ä¡·áÁ¦ÀÇ ÀüÀÚ ¾à±¹ È®´ë, À½°æ ÀÓÇöõÆ® ±â¼úÀÇ ¹ßÀü, ¹ß±âºÎÀü Áø´ÜÀÇ ±â¼ú Çõ½Å, ¹ß±âºÎÀüÀÇ ±Ùº» ¿øÀÎÀ» °Ü³ÉÇÑ »õ·Î¿î Ä¡·á¹ý °³¹ß, º¸´Ù È¿°úÀûÀÎ Æ÷½ºÆ÷µð¿¡½ºÅͶó¾ÆÁ¦ 5Çü ¾ïÁ¦Á¦ µµÀÔ µîÀ» µé ¼ö ÀÖ½À´Ï´Ù.

»ýȰ½À°üº´ÀÇ À¯º´·ü Áõ°¡´Â ¹ß±âºÎÀü ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. »ýȰ½À°üº´Àº ÁÖ·Î ºÒ±ÔÄ¢ÇÑ ½Ä½À°ü, ¿îµ¿ ºÎÁ·, Èí¿¬, °úµµÇÑ À½ÁÖ¿Í °°Àº °Ç°­¿¡ ÇØ·Î¿î ½À°üÀ¸·Î ÀÎÇØ ¹ß»ýÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ÁúȯÀ» Áõ°¡½ÃŰ´Â ¿äÀÎÀ¸·Î´Â Á½ĻýȰ Áõ°¡, ½Ä½À°ü Àå¾Ö, ½ºÆ®·¹½º, ºÒ°Ç°­ÇÑ ½À°ü µîÀÌ ÀÖ½À´Ï´Ù. ¹ß±âºÎÀü(ED)Àº ½ÉÇ÷°ü°è Áúȯ°ú ´ç´¢º´À» Æ÷ÇÔÇÑ »ýȰ½À°üº´ÀÇ Á¶±â ÁöÇ¥°¡ µÇ´Â °æ¿ì°¡ ¸¹¾Æ Àû½Ã¿¡ ÀÇ·áÀû °³ÀÔ°ú °Ç°­ÇÑ »ýȰ½À°ü °³¼±ÀÌ Áß¿äÇÏ´Ù´Â Á¡À» °­Á¶Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2022³â 5¿ù ¿µ±¹ÀÇ ºñ¿µ¸®´ÜüÀÎ ¼¼°èºñ¸¸¿¬¸ÍÀº 2030³â±îÁö Àü ¼¼°è 10¾ï ¸í(¿©¼º 5¸í Áß 1¸í, ³²¼º 7¸í Áß 1¸í)ÀÌ ºñ¸¸°ú ÇÔ²² »ýȰÇÒ °ÍÀ¸·Î ¿¹ÃøµÈ´Ù°í º¸°íÇß½À´Ï´Ù. ÀÌ ¼öÄ¡´Â 2035³â±îÁö Àü ¼¼°è Àα¸ÀÇ 51%¿¡ ÇØ´çÇÏ´Â 40¾ï ¸íÀÌ °úüÁß ¶Ç´Â ºñ¸¸ÀÌ µÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. µû¶ó¼­ »ýȰ½À°üº´ À¯º´·ü Áõ°¡´Â ¹ß±âºÎÀü Ä¡·áÁ¦ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¹ß±âºÎÀü Ä¡·áÁ¦ ½ÃÀåÀÇ ÁÖ¿ä ¾÷üµéÀº ¹ß±âºÎÀü ȯÀڵ鿡°Ô ´õ ½±°í Æí¸®ÇÑ Ä¡·á ¿É¼ÇÀ» Á¦°øÇϱâ À§ÇØ ÀϹÝÀǾàǰ(OTC) Á©°ú °°Àº Çõ½ÅÀûÀÎ Á¦Ç° °³¹ß¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. OTC Á©Àº ó¹æÀü ¾øÀÌ ±¸ÀÔÇÒ ¼ö ÀÖ´Â ¿Ü¿ëÁ¦·Î, ƯÁ¤ Áõ»óÀ» Ä¡·áÇϱâ À§ÇØ ÇǺο¡ Á÷Á¢ ¹Ù¸£´Â ¿Ü¿ëÁ¦·Î, ½ÃÀå µµ´Þ ¹üÀ§¸¦ ³ÐÈ÷°í ¹ÌÃæÁ·µÈ ȯÀÚ ´ÏÁ ÃæÁ·½ÃŰ´Â °ÍÀ» ¸ñÇ¥·Î Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 9¿ù ¿µ±¹ ¼ÒºñÀÚ ÇコÄÉ¾î ±â¾÷ Haleon plc´Â ¹ß±âºÎÀü Ä¡·áÁ¦·Î´Â ÃÖÃÊ·Î FDA ½ÂÀÎÀ» ¹ÞÀº ¹ß±âºÎÀü Ä¡·áÁ¦ÀÎ EroxonÀ» Ãâ½ÃÇß½À´Ï´Ù. ÀÌ È¹±âÀûÀÎ Á¦Ç°Àº ºñħ½ÀÀûÀ̰í Áï°¢ÀûÀÎ ¼Ö·ç¼ÇÀ» Á¦°øÇÏ¿© ȯÀÚÀÇ ÆíÀǼºÀ» Çâ»ó½Ãų ¼ö ÀÖµµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù. ÀÌ Á¦Ç°Àº ¿Ü¿ëÁ¦À̱⠶§¹®¿¡ º¹¿ëÇÒ Çʿ䰡 ¾øÀ¸¸ç, ÀáÀçÀûÀÎ Àü½Å ºÎÀÛ¿ëÀ» ÁÙÀ̰í, ´ëü Ä¡·á ¿É¼ÇÀ» Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - °Å½Ã°æÁ¦ ½Ã³ª¸®¿À ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ½ÅÇü Äڷγª¹ÙÀÌ·¯½º ¿µÇâ°ú ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°/±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀå ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Erectile dysfunction (ED) is the inability to achieve or sustain an erection adequate for satisfactory sexual performance. It is a prevalent condition influenced by physical, psychological, and lifestyle factors, impacting men's overall well-being and quality of life.

The primary product categories for erectile dysfunction include drugs and devices. Drugs are chemical formulations designed to improve blood flow to the penis, enabling men to attain and maintain an erection. These products are distributed through hospital pharmacies, retail pharmacies, and online channels, serving end users such as hospitals and clinics, ambulatory surgery centers, pharmacies, and other healthcare providers.

The erectile dysfunction market research report is one of a series of new reports from The Business Research Company that provides erectile dysfunction market statistics, including erectile dysfunction industry global market size, regional shares, competitors with an erectile dysfunction market share, detailed erectile dysfunction market segments, market trends and opportunities, and any further data you may need to thrive in the erectile dysfunction industry. This erectile dysfunction market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The erectile dysfunction market size has grown strongly in recent years. It will grow from $2.46 billion in 2024 to $2.69 billion in 2025 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period was driven by the increasing incidence of cardiovascular diseases, the rising prevalence of diabetes, greater awareness of erectile dysfunction as a medical condition, an aging population contributing to higher ED cases, and a growing preference for personalized treatment options.

The erectile dysfunction market size is expected to see strong growth in the next few years. It will grow to $3.78 billion in 2029 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period is expected to be driven by an increase in psychological factors, higher rates of obesity and metabolic disorders, rising demand for non-invasive erectile dysfunction treatments, a growing number of patient consultations for sexual health, and increasing government initiatives promoting men's health and addressing lifestyle-related risk factors. Key trends include the expansion of e-pharmacies for erectile dysfunction drugs, advancements in penile implant technologies, technological innovations in erectile dysfunction diagnostics, the development of novel treatment methods targeting the root causes of ED, and the introduction of more effective phosphodiesterase type 5 inhibitors.

The increasing prevalence of lifestyle-related diseases is expected to drive growth in the erectile dysfunction market. Lifestyle-related diseases are primarily caused by unhealthy habits such as poor diet, lack of physical activity, smoking, and excessive alcohol consumption. Factors contributing to the rise in these conditions include increased sedentary behavior, poor dietary choices, stress, and unhealthy habits. Erectile dysfunction (ED) is often an early indicator of lifestyle-related diseases, including cardiovascular conditions and diabetes, emphasizing the importance of timely medical intervention and healthier lifestyle changes. For example, in May 2022, the World Obesity Federation, a UK-based non-profit organization, reported that by 2030, one billion people worldwide equivalent to one in five women and one in seven men are projected to be living with obesity. This figure is expected to rise to four billion people, or 51% of the global population, who will be either overweight or obese by 2035. The increasing prevalence of lifestyle-related diseases is, therefore, expected to drive the growth of the erectile dysfunction market.

Leading companies in the erectile dysfunction market are focusing on developing innovative products, such as over-the-counter (OTC) gels, to provide more accessible and convenient treatment options for individuals with ED. This approach aims to expand market reach and address unmet patient needs. An OTC gel is a topical medication available without a prescription, applied directly to the skin to treat specific conditions. For instance, in September 2024, Haleon plc, a UK-based consumer healthcare company, introduced Eroxon, the first FDA-cleared over-the-counter gel for erectile dysfunction. This groundbreaking product offers a non-invasive, fast-acting solution designed to improve accessibility and convenience for patients. Its topical application eliminates the need for oral medications, reducing potential systemic side effects and providing an alternative treatment option.

In September 2022, Advanced MedTech Holdings, a Singapore-based medical device company, acquired Shenzhen Wikkon Medical Apparatus Co. Ltd. for an undisclosed amount. This acquisition strengthens Advanced MedTech Holdings' presence in the urology sector in China by leveraging Wikkon's expertise in developing and manufacturing urology and shock wave therapy devices. Shenzhen Wikkon Medical Apparatus Co. Ltd., a China-based company, specializes in extracorporeal shock wave therapy (ESWT) for treating conditions such as erectile dysfunction and urinary stones.

Major players in the erectile dysfunction market are Pfizer Inc., Bayer AG, Dong-A Socio Holdings Co. Ltd., Sanofi S.A., GlaxoSmithKline plc, Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Limited, Boston Scientific Corporation, Sandoz International GmbH, Sun Pharmaceutical Industries Limited, Coloplast Corporation, Dr. Reddy's Laboratories Limited, Cipla Limited, Ferring Pharmaceuticals A/S, Endo International plc, Zydus Lifesciences Limited, Lupin Limited, Hims & Hers Health Inc., Cadila Pharmaceuticals Limited, VIVUS Inc., Rigicon Inc., Petros Pharmaceuticals Inc., Futura Medical plc, Apricus Biosciences Inc., Pos-T-Vac Medical Inc., Initiator Pharma A/S.

North America was the largest region in the erectile dysfunction market in 2024. The regions covered in erectile dysfunction report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the erectile dysfunction market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The erectile dysfunction market consists of sales of medications, devices, and therapies aimed at treating erectile dysfunction. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Erectile Dysfunction Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on erectile dysfunction market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for erectile dysfunction ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The erectile dysfunction market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Erectile Dysfunction Market Characteristics

3. Erectile Dysfunction Market Trends And Strategies

4. Erectile Dysfunction Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Erectile Dysfunction Growth Analysis And Strategic Analysis Framework

6. Erectile Dysfunction Market Segmentation

7. Erectile Dysfunction Market Regional And Country Analysis

8. Asia-Pacific Erectile Dysfunction Market

9. China Erectile Dysfunction Market

10. India Erectile Dysfunction Market

11. Japan Erectile Dysfunction Market

12. Australia Erectile Dysfunction Market

13. Indonesia Erectile Dysfunction Market

14. South Korea Erectile Dysfunction Market

15. Western Europe Erectile Dysfunction Market

16. UK Erectile Dysfunction Market

17. Germany Erectile Dysfunction Market

18. France Erectile Dysfunction Market

19. Italy Erectile Dysfunction Market

20. Spain Erectile Dysfunction Market

21. Eastern Europe Erectile Dysfunction Market

22. Russia Erectile Dysfunction Market

23. North America Erectile Dysfunction Market

24. USA Erectile Dysfunction Market

25. Canada Erectile Dysfunction Market

26. South America Erectile Dysfunction Market

27. Brazil Erectile Dysfunction Market

28. Middle East Erectile Dysfunction Market

29. Africa Erectile Dysfunction Market

30. Erectile Dysfunction Market Competitive Landscape And Company Profiles

31. Erectile Dysfunction Market Other Major And Innovative Companies

32. Global Erectile Dysfunction Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Erectile Dysfunction Market

34. Recent Developments In The Erectile Dysfunction Market

35. Erectile Dysfunction Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â